Ticlopidine, Platelets and Vascular Disease (Paperback, Softcover reprint of the original 1st ed. 1993)

Blood platelets lack a nucleus. As a result their life span is short and they cannot reproduce themselves. Platelets share these qualities with the red blood cell. Plate lets and red blood cells, nevertheless, serve vital roles in the body. One major function of the platelet is its capacity to aggregate and thereby initiate intravas cular coagulation which often underlies such major diseases as myocardial infarc tion, cerebral infarction, and pulmonary embolism. For this reason in recent years, medical attention has been directed to drugs that inhibit platelet aggregation. Aspirin was the first drug to be proven effective in this area. Since then other drugs that share aspirin's fundamental biochemical action, inhibition of platelet cyclooxygenase, have also been studied. Very recently, ticlopidine, the first of what promises to be a new class of drugs inhibiting platelet aggregation and coagulation via an entirely different biochemical mechanism, has been exten sively studied and clinically shown to be as effective or more effective than aspirin in the prevention of ischemic cardiovascular and cerebrovascular disease."

General

Imprint:	Springer-Verlag New York
Country of origin:	United States
Release date:	November 2011
First published:	1993
Editors:	William K. Hass • J. Donald Easton
Dimensions:	235 x 155 x 9mm (L x W x T)
Format:	Paperback
Pages:	162
Edition:	Softcover reprint of the original 1st ed. 1993
ISBN-13:	978-1-4613-8308-6
Categories:	Books > Medicine > Clinical & internal medicine > Cardiovascular medicine Books > Medicine > Other branches of medicine > Pharmacology > General Promotions
LSN:	1-4613-8308-0
Barcode:	9781461383086

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!